Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rheumatoid arthritis (RA) patients who failed to respond to initial treatment with rituximab (RTX) (a chimeric monoclonal antibody against the protein CD20) can still be successfully re-treated with a second course of RTX after six months, according to the results of a new study.

   

Today in Popular Press...keeping you current

Breakthrough May Pave the Way for Therapeutic Vaccines
ScienceDaily, 12/18/09

Should flowers be banned in hospitals?
ScienceDaily, 12/18/09

Negative emotions outweigh intent to exercise at health clubs
ScienceDaily, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address